Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 22:22:38 GMT 2025
by
admin
on
Tue Apr 01 22:22:38 GMT 2025
|
| Protein Sub Type | IGE |
| Sequence Origin | HUMAN |
| Sequence Type | INCOMPLETE |
| Record UNII |
AF59OKU9U8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AF59OKU9U8
Created by
admin on Tue Apr 01 22:22:38 GMT 2025 , Edited by admin on Tue Apr 01 22:22:38 GMT 2025
|
PRIMARY | |||
|
P01854
Created by
admin on Tue Apr 01 22:22:38 GMT 2025 , Edited by admin on Tue Apr 01 22:22:38 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_14 | 2_14 |
| 1_15 | 1_101 |
| 1_29 | 1_83 |
| 1_117 | 2_117 |
| 1_130 | 1_188 |
| 1_204 | 2_204 |
| 1_234 | 1_294 |
| 1_340 | 1_400 |
| 2_15 | 2_101 |
| 2_29 | 2_83 |
| 2_130 | 2_188 |
| 2_234 | 2_294 |
| 2_340 | 2_400 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_21 |
| N | 1_49 |
| N | 1_95 |
| N | 1_141 |
| N | 1_247 |
| N | 1_259 |
| N | 1_270 |
| N | 2_21 |
| N | 2_49 |
| N | 2_95 |
| N | 2_141 |
| N | 2_247 |
| N | 2_259 |
| N | 2_270 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
Omalizumab inhibits the binding of IgE to Fc?RI on mast cells and basophils by binding to an antigenic epitope on IgE that overlaps with the site to which Fc?RI binds.
BINDING
|
||
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
BINDER->LIGAND | |||
|
|
LIGAND->TARGET |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|